• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Unichem gets US FDA approval for Atenolol and Chlorthalidone Tablets

expresspharmaNovember 30, 2020

Tag: Unichem Laboratories , FDA , Atenolol , Chlorthalidone

Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations.

Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure.

The product will be commercialized from Unichem’s Ghaziabad Plant.

Previous:Global Demand For COVID-19 Products Presents Huge Opportunities for the Biomanufacturing Sector

Next:Dr Reddy’s to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Unichem gets US FDA approval for Atenolol and Chlorthalidone Tablets | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Compliance FDA 21 part 11 Packaging leak tester for pharmaceuticals

Compliance FDA 21 part 11 Packaging leak tester for pharmaceuticals
Ivermectin (FDA)

Ivermectin (FDA)
Fluorfenicol( FDA)

Fluorfenicol( FDA)
Aciclovir (FDA)

Aciclovir (FDA)
HFHA(m-6FDAP)

HFHA(m-6FDAP)
Prednisolone (FDA /COS)

Prednisolone (FDA /COS)
99% up, DMF, FDA (zero defect) Emtricitabine 143491-57-0

99% up, DMF, FDA (zero defect) Emtricitabine 143491-57-0
Deltamine (FDA)

Deltamine (FDA)
Nabumetone (FDA)

Nabumetone (FDA)
Atenolol EP Impurity A

Atenolol EP Impurity A

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service